APEN News and Press, Apollo Endosurgery Inc. From 11/29/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: venusvi / Shutterstock.com One of the medical technology sector’s most dynamic players is maneuvering to gain a bigger market share. This morning, Boston Scientific (NYSE: BSX ) announced that it is...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time for another dive into the biggest pre-market stock movers with the shares rising and falling on Tuesday! Moving shares today is an acquisition deal, public stock of...

Boston Scientific to acquire Apollo for $10.00 per share in cash AUSTIN, TX / ACCESSWIRE / November 29, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a leading minimally invasive medical device company for gastrointestinal and bariatric procedures, announced today it has ent...

Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc. PR Newswire Acquisition to expand endoluminal surgery portfolio and add differentiated technologies for endobariatric procedures MARLBOROUGH, Mass. , Nov. 29, 2022 /PRNewswi...

OverStitch has new indications for use statement under CE-Mark, including indications for defect closure, stent fixation, endoscopic sleeve gastroplasty and transoral outlet reduction AUSTIN, TX / ACCESSWIRE / November 21, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a glob...

AUSTIN, TX / ACCESSWIRE / November 7, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that its senior management team will host investor meetings at four investor co...

Apollo Endosurgery, Inc. (APEN) Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Matt Kreps – Investor Relations Chas McKhann – Chief Executive Officer Jeff Black – Chief Financial Officer Conference Cal...

The following slide deck was published by Apollo Endosurgery, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Apollo Endosurgery, Inc. 2022 Q3 - Results - Earnings Call Presentation

Apollo Endosurgery press release ( NASDAQ: APEN ): Q3 GAAP EPS of -$0.28 misses by $0.05 . Revenue of $19.57M (+19.7% Y/Y) beats by $1.42M . The company is raising its FY2022 revenue guidance to be in the range of $75M to $76M vs. consensus of $73.95M. Fo...

Grew global revenue 20% GAAP, 24% in constant currency Received FDA authorization for Apollo ESG TM and Apollo REVISE TM systems for treating patients with obesity AUSTIN, TX / ACCESSWIRE / November 1, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in l...